Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Frank Borriello, PhD,MD
CHIEF EXECUTIVE OFFICER, ALLOPLEX BIOTHERAPEUTICS
Benefits and Limitations of De-Centralizing Cell Therapy Manufacturing and Clinical Development
Woburn MA01801, Massachusetts, United States
Greg Bosch
CHAIRMAN & CEO, PANAVANCE THERAPEUTICS INC.
Panavance Therapeutics Inc.
Berwyn, Pennsylvania, United States
Torie Bosch
EDITOR, FIRST OPINION, STAT
A New Framework for Applying AI to Mental Health Drug Development
Avirup Bose, PhD
VICE PRESIDENT OF BUSINESS DEVELOPMENT, CHINOOK THERAPEUTICS
Driving the Rare Disease Innovation Pipeline to Bring New Products to Market
Cambridge, Massachusetts, United States
Susan Botegga
CLL CAREGIVER/PATIENT ADVOCATE
The Intersection of Cancer and Mental Health: Improving Equity and Access to Quality Care
Robert Boyce, ACA
CEO, PLAKOUS THERAPEUTICS, INC.
Plakous Therapeutics, Inc.
Winston Salem, North Carolina, United States
Brian Bradbury
VICE PRESIDENT, AMGEN INC.
Real-World Evidence in Regulatory Decision-Making: Enabling its Use Through International CReal-World Evidence in Regulatory Decision-Making: Enabling its Use Through International Collaboration
Jennifer Bright, MPA
CHIEF STRATEGY & ENGAGEMENT OFFICER, INNOVATION AND VALUE INITIATIVE
Bringing Value Assessments into the 21st Century: A Multi-Stakeholder Perspective
Washington, United States
Rick Bright, PhD
FORMER CHIEF EXECUTIVE OFFICE, PANDEMIC PREVENTION INSTITUTE (PPI) AT THE ROCKERFELLER FOUNDATION
AI For Good: Making sense of big data and high tech to Cure What Ails Us
Dennis Brown
Kintara Therapeutics